Lords Mark Microbiotech Pvt. Ltd. a subsidiary of the Lords Mark industries limited has been accredited by the National Accreditation Board of Testing and Calibration Laboratories (NABL) to serve as a well-established laboratory validation that positions the company in the company among the most reliable and quality assured diagnostic provider in India. This difference emphasizes the fact that the organization is of high quality in testing accuracy, reporting, and patient confidence.
On the same milestone, the company has announced a national growth agenda to have 200 laboratories and 2,000 collection centres in the next two years making it one of the top five organised pathology players in the country. The current 12 developed laboratories and 68 collection centres are the main support of this scale-up with good expertise in instrumentation and a smooth integration of standard pathology and genomic screening within a single ecosystem.
Another major innovation facilitating differentiation is the individualised Organ Health Score, the smart model of health assessment of an individual offered by the company, which gives them specific guidance regarding early diagnosis and preventive health measures that are a shift in episodic diagnosis to an ongoing and proactive approach to health management.
Talking on the accreditation and strategic vision, Mr. Subodh Gupta, CEO, Lords Mark Microbiotech Pvt. Ltd., stated as follows: NABL accreditation is a recognitive milestone in our life and thus reflects our pertinacious dedication towards precision, quality and trust. It reinforces our vision of transforming preventive healthcare in India to be based on advanced diagnostics and genomic intelligence. We are not simply interested in building more infrastructure, but in transforming access, empowering people with personalised health data, and re-engineering access to act early. This is where the future of diagnostics will commence at Lords Mark Microbiotech.
Based on the quality validation concept and the purpose-driven expansion strategy, the Lords Mark Microbiotech is set to help India jump into the more accessible, technology-enabled, preventive healthcare environment, in which disease prevention becomes the average rather than the exception.
https://mydna.lordsmicrobiotech.com/
Moneycontrol Journalists are not involved in creation of this article.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
